Insider · CIK 0001748462
Thomas B Smith
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC). First filing Sep 3, 2025, latest Sep 3, 2025.
Thomas B Smith files SEC Form 4 as officer at COLL (COLLEGIUM PHARMACEUTICAL, INC). Since Sep 3, 2025, Thomas B Smith has reported 0 open-market buys worth $0 and 1 open-market sell worth $672k, the latest filed on Sep 3, 2025.
A track record needs three past buys with six months of prices behind them; Thomas B Smith has 0, so none is measured yet.
The newest scored trade: sold $672k of COLL on Aug 29, 2025, filed Sep 3, 2025, scored 55 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
COLL: COLLEGIUM PHARMACEUTICAL, INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | COLLEGIUM PHARMACEUTICAL, INC | $672k 17,478 shares | -20% | +57% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 29, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | 17,478 0.06% of outstanding | $672k | Aug 29, 2025 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +14,268 | $0.00 | $0 | 85,312 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +22,774 | $0.00 | $0 | 108,086 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -5,897 | $46.75 | $276k | 102,189 | Feb 12, 2026 |
| Feb 10, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -11,538 | $46.75 | $539k | 90,651 | Feb 12, 2026 |
| Aug 29, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | SOpen-market sale Common Stock | -17,478 | $38.42 | $672k | 70,264 | Sep 3, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +33,762 | $0.00 | $0 | 88,326 | Feb 12, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +5,313 | $0.00 | $0 | 93,639 | Feb 12, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -1,498 | $30.52 | $46k | 92,141 | Feb 12, 2025 |
| Feb 10, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | FTax withholding Common Stock | -4,399 | $30.52 | $134k | 87,742 | Feb 12, 2025 |
Questions about Thomas B Smith
Answered from the filings on this page, as of the latest one.
Is Thomas B Smith buying or selling?
Not in the last 12 months. Thomas B Smith's latest open-market trade on SEC Form 4 was sold $672k of COLL on Aug 29, 2025.
How did Thomas B Smith's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas B Smith has 0.
Where does Thomas B Smith file Form 4?
Thomas B Smith has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC) as EVP and Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.